Clinical Trial Supplies Market, By Phase (Phase III, Phase II, and Phase I), By Product & Services (Supply Chain Management, Storage & Distribution, and Manufacturing), By Therapeutic Use (CNS, Oncology, Cardiovascular, Metabolic Disorders, and Infectious Disease), By End Use (Medical Device, Biologics, and Pharmaceuticals), and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026
REPORT HIGHLIGHT
The clinical trial supplies market was valued at USD 1.68 billion by 2019, growing with 10.8% CAGR during the forecast period, 2020-2026.
A clinical trial is the part of medical research that determines if a medical strategy, device, or treatment is useful, effective, and safe for human use. These studies assist in finding which medical experiment approaches is best for particular diseases. A clinical trial delivers the best data for healthcare decision-making. The purpose of a clinical trial is to study strict scientific standards. These standards help in producing reliable study results by protecting patients. Clinical trials are the last stage in drug development in a long as well as careful research process, which is carried out by researchers or scientists for a certain disease.
Market Dynamics
An increase in the number of clinical trials & globalization, growing complexities, and the increasing number of biosimilars and biologics drugs in trials are the major factors boosting the growth of the global clinical trial supplies market. Biosimilars are licensed or approved by the FDA as they are vastly similar to a biological product already approved by the FDA. For instance, the latest clinical phase I trial was conducted in June 2020 regarding the deployment and development of at-home strength and training program to support a phase I trials in the person suffering from chronic spinal cord injury. In addition, several trials are also been conducted in recent times to introduce vaccination for COVID-19 disease. Furthermore, the growing adoption of supply chain management systems owing to increasing pressure to cut down research & development cost and thereby, increase the operational efficiency will fuel the market growth in the forecast period. However, lack of infrastructure and shortage of trained professionals are predicted to hamper the market growth. On the contrary, technological advancements in supply chain management and the focus of new entrants on developing novel products are expected to provide lucrative growth opportunities for market growth in the coming future.
Clinical Phase Takeaway
“Phase I segment to be the fastest-growing market till 2026”
Based on phase, the global market for clinical trial supplies is trifurcated into phase III, phase II, and phase I. Of these, the phase I segment accounted for the largest market share in 2019 and is anticipated to grow at the fastest pace during the forecast period. This is majorly owing to the globalization of these trials
This growth is majorly owing to the increase in the number of outsourced phase-I clinical trials. High capital investments and a lesser sample population are the key factors liable for outsourcing the major volumes of these trials. This number is estimated to increase due to the globalization of these trials. On the other hand, the phase III trials segment is estimated to possess a high level of complexity than the phase I and phase II trials. This is mainly because these trials are difficult to design & run and are time-consuming.
Product & Services Takeaway
“Supply chain management segment to be most lucrative during the forecast period”
On the basis of products & services, the overall clinical trial supplies market is categorized into supply chain management, storage & distribution, and manufacturing. Among these, the storage & distribution segment accounted for a significant market share in 2019 and is projected to witness the fastest growth during the forecast period. This is primarily owing to the increase in the number of clinical trials and the rising outsourcing of storage & distribution services across the globe. The storage & distribution segment is further sub-categorized into cold chain based and non-cold chain based.
Therapeutic Use Takeaway
“Oncology segment to grow at a significant rate by 2026”
Based on therapeutic use, the worldwide market is categorized into CNS, oncology, cardiovascular, metabolic disorders, and infectious disease. Of these, the oncology segment estimated the fastest growth till 2019 and is anticipated to dominate the industry during the period of forecast. This is mainly due to the growing prevalence of cancer across the world coupled with rising demand for oncology drugs. In addition, the oncology clinical trials correspond to a higher share of clinical trials in the dataset for several countries across the globe due to increasing R&D expenditure, which will drive the segmental growth during the forecast period.
End-Use Takeaway
“Pharmaceuticals segment to hold the largest market share in the forecast period”
On the basis of end-use, the global market is classified into a medical device, biologics, and pharmaceuticals. Of these, the pharmaceutical segment accounted for the largest market share in 2019 and is expected to continue its trend during the forecast period. A steady decrease in the research & development pipeline for pharmaceutical drugs is witnessed over the last few years, which is expected to propel the segmental market growth. The demand for biosimilars in both developed and developing countries is also likely to boost the market growth.
Regional Takeaway
“North America region to be the largest contributor to the market growth”
Depending on the region, the global industry is divided into Europe, North America, Middle East & Africa, Asia Pacific, and Latin America. The North America region is the largest contributor to the global clinical trial supplies industry growth owing to the rise in the number of ongoing R&D activities and the presence of multinational biotechnology & pharmaceutical companies in the region. In addition, the advanced healthcare infrastructure and the active participation of key players in drug discovery processes are other factors boosting the regional market growth.
On the other hand, the Asia Pacific market for clinical trial supplies is projected to witness the fastest growth by 2026 owing to growing prevalence of chronic diseases and low costs associated with conducting clinical trials in the region. Besides, the growing government initiatives for conducting clinical trials are impelling the regional market growth.
COVID-19 Impact
Stay at home orders and restrictions on movements are helping to prevent the spread of deadly COVID-19 virus. However, successful strategies against this worldwide health threat are creating pressure on the global clinical trial supplies market to find effective treatment and cure for a myriad of diseases. While the healthcare communities have reformed in efforts to develop vaccines and therapeutics for COVID-19, the other trials already in the R&D pipeline and underway cannot be forgotten that will also help conquer other diseases. Thus, there is an urgent need to use innovative and advanced approaches to start new studies and ensure the continuity of existing trials.
The current COVID-19 pandemic is underscoring the need to monitor the landscape of clinical trials, identify and expand new approaches, and employ solutions. These are some important steps for trial sponsors, clinicians, contract research organizations, and most significantly patients, to have the means to rise above the fight against coronavirus, which has halted or slowed down the advancements in therapeutics and vaccines.
Key Vendor Takeaway
The leading players operating in the global clinical trial supplies industry include KLIFO A/S, Almac Group Ltd., Catalent Pharma Solutions, Movianto GmbH, Biocair International Ltd., Patheon Inc., PCI Services, Sharp Packaging Services, Thermo Fischer Scientific, and PAREXEL International Corporation.
In September 2019, Thermo Fisher Scientific announced an expansion of their distribution services network and integrated clinical trial supply, in Suzhou, China. The company has also entered into a collaboration with Frontier Biotechnologies Inc. to develop a new treatment for HIV.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CLINICAL TRIAL SUPPLIES MARKET KEY PLAYERS
- KLIFO A/S
- Almac Group Ltd.
- CatalentPharma Solutions
- Movianto GmbH
- Biocair International Ltd.
- Patheon Inc.
- PCI Services
- Sharp Packaging Services
- Thermo Fischer Scientific
- PAREXEL International Corporation
GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
- Phase I
- Phase II
- Phase III
- Others
GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY PRODUCT & SERVICES
- Supply Chain Management
- Storage & Distribution
- Cold chain based
- Non-cold chain based
- Manufacturing
GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
- CNS
- Oncology
- Cardiovascular
- Metabolic Disorders
- Infectious Disease
- Others
GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY END-USE
- Medical Device
- Biologics
- Pharmaceuticals
- Others
GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. CLINICAL TRIAL SUPPLIES MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Clinical Phase
2.1.2. Market Snippet by Products & Services
2.1.3. Market Snippet by Therapeutic Use
2.1.4. Market Snippet by End Use
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. CLINICAL TRIAL SUPPLIES KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CLINICAL TRIAL SUPPLIES INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. CLINICAL TRIAL SUPPLIES MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. CLINICAL TRIAL SUPPLIES MARKET – BY CLINICAL PHASE
6.1. Overview
6.1.1. Segment Share Analysis, By Clinical Phase, 2019 & 2026 (%)
6.2. Phase I
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Phase II
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Phase III
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.5. Others
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. CLINICAL TRIAL SUPPLIES MARKET – BY PRODUCTS & SERVICES
7.1. Overview
7.1.1. Segment Share Analysis, By Clinical Phase, 2019 & 2026 (%)
7.2. Supply Chain Management
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Storage & Distribution
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.2.1. Cold chain based
7.3.2.1.1. Overview
7.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.2.2. Non-cold chain based
7.3.2.2.1. Overview
7.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Manufacturing
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. CLINICAL TRIAL SUPPLIES MARKET – BY THERAPEUTIC USE
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Use, 2019 & 2026 (%)
8.2. CNS
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Oncology
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Cardiovascular
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Metabolic Disorders
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6. Infectious Disease
8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.7. Others
8.7.1. Overview
8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. CLINICAL TRIAL SUPPLIES MARKET – BY END USE
9.1. Overview
9.1.1. Segment Share Analysis, By Clinical Phase, 2019 & 2026 (%)
9.2. Medical Device
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3. Biologics
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4. Pharmaceuticals
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5. Others
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10. CLINICAL TRIAL SUPPLIES MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.2.4. North America Market Size and Forecast, By Clinical Phase, 2015 – 2026 (US$ Million)
10.2.5. North America Market Size and Forecast, By Products & Services, 2015 – 2026 (US$ Million)
10.2.6. North America Market Size and Forecast, By Therapeutic Use, 2015 – 2026 (US$ Million)
10.2.7. North America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.2.8. U.S.
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.2.9. Canada
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Clinical Phase, 2015 – 2026 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Products & Services, 2015 – 2026 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Therapeutic Use, 2015 – 2026 (US$ Million)
10.3.7. Europe Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.3.8. Germany
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.10. United Kingdom
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.11. France
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.12. Rest of Europe
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Clinical Phase, 2015 – 2026 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Products & Services, 2015 – 2026 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Use, 2015 – 2026 (US$ Million)
10.4.7. Asia Pacific Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.9. China
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.11. South Korea
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.12. Rest of APAC
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Clinical Phase, 2015 – 2026 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Products & Services, 2015 – 2026 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Therapeutic Use, 2015 – 2026 (US$ Million)
10.5.7. Latin America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.5.8. Brazil
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.9. Mexico
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.10. Argentina
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Clinical Phase, 2015 – 2026 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Products & Services, 2015 – 2026 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Use, 2015 – 2026 (US$ Million)
10.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.6.8. Saudi Arabia
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6.9. United Arab Emirates
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. KLIFO A/S
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Clinical Phase Benchmarking
11.1.4. Strategic Initiatives
11.2. Almac Group Ltd.
11.3. Catalent Pharma Solutions
11.4. Movianto GmbH
11.5. Biocair International Ltd.
11.6. Patheon Inc.
11.7. PCI Services
11.8. Sharp Packaging Services
11.9. Thermo Fischer Scientific
11.10. PAREXEL International Corporation
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Clinical Trial Supplies market: Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Clinical Phase
TABLE Global Clinical Trial Supplies market, by Clinical Phase2015-2026 (USD Million)
TABLE Clinical Trial Supplies market: Products & Services Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Products & Services
TABLE Global Clinical Trial Supplies market, by Products & Services 2015-2026 (USD Million)
TABLE Clinical Trial Supplies market: Therapeutic UseSnapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Therapeutic Use
TABLE Global Clinical Trial Supplies market, by Therapeutic Use2015-2026 (USD Million)
TABLE Clinical Trial Supplies market: End Use Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End Use
TABLE Global Clinical Trial Supplies market, by End Use 2015-2026 (USD Million)
TABLE Clinical Trial Supplies market: RegionalSnapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Clinical Trial Supplies market, by Region 2015-2026 (USD Million)
TABLE North America Clinical Trial Supplies market, by Country, 2015-2026 (USD Million)
TABLE North America Clinical Trial Supplies market, by Clinical Phase, 2015-2026 (USD Million)
TABLE North America Clinical Trial Supplies market, by Products & Services, 2015-2026 (USD Million)
TABLE North America Clinical Trial Supplies market, by Therapeutic Use, 2015-2026 (USD Million)
TABLE North America Clinical Trial Supplies market, by End Use, 2015-2026 (USD Million)
TABLE Europe Clinical Trial Supplies market, by Country, 2015-2026 (USD Million)
TABLE Europe Clinical Trial Supplies market, by Clinical Phase, 2015-2026 (USD Million)
TABLE Europe Clinical Trial Supplies market, by Products & Services, 2015-2026 (USD Million)
TABLE Europe Clinical Trial Supplies market, by Therapeutic Use, 2015-2026 (USD Million)
TABLE Europe Clinical Trial Supplies market, by End Use, 2015-2026 (USD Million)
TABLE Asia Pacific Clinical Trial Supplies market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Clinical Trial Supplies market, by Clinical Phase, 2015-2026 (USD Million)
TABLEAsia Pacific Clinical Trial Supplies market, by Products & Services, 2015-2026 (USD Million)
TABLE Asia Pacific Clinical Trial Supplies market, by Therapeutic Use, 2015-2026 (USD Million)
TABLE Asia Pacific Clinical Trial Supplies market, by End Use, 2015-2026 (USD Million)
TABLE Latin America Clinical Trial Supplies market, by Country, 2015-2026 (USD Million)
TABLE Latin America Clinical Trial Supplies market, by Clinical Phase, 2015-2026 (USD Million)
TABLE Latin America Clinical Trial Supplies market, by Products & Services, 2015-2026 (USD Million)
TABLE Latin America Clinical Trial Supplies market, by Therapeutic Use, 2015-2026 (USD Million)
TABLE Latin America Clinical Trial Supplies market, by End Use, 2015-2026 (USD Million)
TABLE Middle East and Africa Clinical Trial Supplies market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Clinical Trial Supplies market, by Clinical Phase, 2015-2026 (USD Million)
TABLE Middle East and Africa Clinical Trial Supplies market, by Products & Services, 2015-2026 (USD Million)
TABLE Middle East and Africa Clinical Trial Supplies market, by Therapeutic Use, 2015-2026 (USD Million)
TABLE Middle East and Africa Clinical Trial Supplies market, by End Use, 2015-2026 (USD Million)
List of Figures
FIGURE Clinical Trial Supplies market segmentation
FIGURE Market Research Methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Clinical Phase segment market share analysis, 2019 & 2026
FIGURE Clinical Phase segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase I market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase II market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Phase III market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Products & Services segment market share analysis, 2019 & 2026
FIGURE Products & Services segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Supply Chain Management market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Storage & Distribution market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cold chain based market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Non-cold chain based market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Manufacturing market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Therapeutic Use segment market share analysis, 2019 & 2026
FIGURE Therapeutic Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE CNS market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cardiovascular market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Metabolic Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Infectious Disease market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE End Use segment market share analysis, 2019 & 2026
FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Medical Device market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Biologics market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Pharmaceuticals market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Clinical Trial Supplies market share and leading players, 2018
FIGURE Europe Clinical Trial Supplies market share and leading players, 2018
FIGURE Asia Pacific Clinical Trial Supplies market share and leading players, 2018
FIGURE Latin America Clinical Trial Supplies market share and leading players, 2018
FIGURE Middle East and Africa Clinical Trial Supplies market share and leading players, 2018
FIGURE North America Clinical Trial Supplies market share analysis by country, 2018
FIGURE U.S. Clinical Trial Supplies Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Clinical Trial Supplies Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Clinical Trial Supplies Market share analysis by country, 2018
FIGURE Germany Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE FranceClinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Clinical Trial Supplies market share analysis by country, 2018
FIGURE India Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin AmericaClinical Trial Supplies market share analysis by country, 2018
FIGURE BrazilClinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Clinical Trial Supplies market share analysis by country, 2018
FIGURE Saudi Arabia Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Clinical Trial Supplies market size, forecast and trend analysis, 2015 to 2026 (USD Million)
